CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioxyne Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioxyne Ltd
Suite 506, Level 5, 50 Clarence Street
Phone: +61 290788180p:+61 290788180 SYDNEY, NSW  2000  Australia Ticker: BXNBXN
Business Summary
Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20236/30/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
5499 Miscellaneous food stores

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board AnthonyHo 12/3/2012 10/30/2012
Chief Executive Officer, Managing Director, Director SamuelWatson 11/17/2023 5/19/2023
Chief Financial Officer, Chief Operating Officer, Company Secretary Guy A.Robertson 5/19/2023 9/1/2016
Director JasonHine 5/19/2023 5/19/2023

Business Names
Business Name
BXN
P.T. GAMAT UTAMA
VRI BioMedical Limited

General Information
Number of Employees: 16 (As of 6/30/2005)
Outstanding Shares: 1,901,645,398 (As of 12/31/2023)
Shareholders: 1,842
Stock Exchange: ASX
Fax Number: +61 290787661


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 1, 2024